ICD-10-CM Billable Code

C84.A5

Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb

Clinical Classification Guidelines

Medical Intelligence & Overview

Cutaneous T-cell lymphoma (CTCL) is a type of cancer that begins in the T-cells, a kind of white blood cell involved in the immune response. When it affects the skin and the lymph nodes of the inguinal (groin) area and lower limbs, it is classified under the ICD-10 code C84.A5. This condition can present with various skin symptoms and may involve lymph node enlargement. While it is an uncommon form of lymphoma, understanding its features can help in recognizing and managing the condition effectively.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting T-cell development and function Potential environmental exposures, including chemicals and pesticides History of immune system suppression or related conditions Chronic skin inflammatory conditions or infections Unknown factors, as precise causes are often not identified

Key Symptoms: Persistent skin patches, plaques, or tumors that may be scaly, reddened, or raised Itching or discomfort in affected skin areas Lymph node swelling in the inguinal (groin) region and along the lower limbs Skin ulcers or sores in advanced stages Possible redness, swelling, or warmth in the overlying skin of swollen lymph nodes General symptoms such as fatigue, weight loss, or fever in advanced cases

Diagnostic & Treatment

Diagnosis Path: The diagnosis process typically involves a combination of clinical evaluation, skin biopsies, and imaging studies. A dermatologist or oncologist will examine the skin and lymph nodes, perform biopsies of affected skin tissue to identify the presence of malignant T-cells, and may order imaging tests like CT scans to assess the extent of lymph node involvement. Blood tests might also be utilized to evaluate overall immune function and detect abnormal cells.

Treatment Protocols: Skin-directed therapies such as topical corticosteroids, retinoids, or chemotherapy agents Phototherapy, including psoralen plus ultraviolet A (PUVA) therapy Systemic treatments like chemotherapy, targeted therapy, or immunotherapy for more advanced cases Radiation therapy to affected lymph node regions Clinical trials exploring novel treatments

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C84.A5 a billable ICD-10 code?
Yes, C84.A5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C84.A5?
Clinical documentation must specify the nature of Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.

Cite this Clinical Reference